Dermatological Therapeutics Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI483121 | Publish Date: May 2024 | No. of Pages: 180

Global Dermatological Therapeutics Market Share

Region-wise, the North American, European, Asia Pacific, Latin American, and Middle East & Africa regions make up the global dermatological therapeutics market. Due to growing healthcare costs, increased awareness of skin issues, and the robust presence of pharmaceutical companies, which are anticipated to drive market expansion, North America is projected to lead the global market. The region's growing activities to raise skin cancer awareness are also fueling market expansion. According to the American Academy of Dermatology Association, unprotected ultraviolet (UV) exposure is the most preventable risk factor for skin cancer. Skin cancer is the most common malignancy in the United States. During the COVID-19 pandemic in 2021, Skin Cancer Awareness Month will be observed, and information will be shared to help save life in the American battle against skin cancer.